Laser treatment through the skin for men with prostate cancer
Part of Cancer, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This trial tests a laser procedure done through the skin between the scrotum and anus, guided by MRI and ultrasound, for men with certain prostate cancer types. It aims to heat and treat prostate cancer while checking safety and outcomes over follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and attend all procedure and follow-up visits
- You have prostate cancer that is considered “intermediate risk,” and it takes up less than one-third of your prostate on MRI
- Your prostate size is between 18 and 100 cubic centimeters on MRI or ultrasound
- Your prostate MRI shows lesions with PI-RADS score 3, 4, or 5
- Your urinary symptoms are not too severe: IPSS is 23 or less, and you do not have significant urine backup after peeing
- You must not have had prior prostate cancer treatment such as radiation or ablation, and you must not have certain bladder/nerve problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive prostate treatment using MRI guidance and a focal laser to destroy only the cancer spot (not the whole prostate). If you have low-to-intermediate risk, MRI-visible prostate cancer in a limited area, it may help control the cancer while potentially reducing treatment side effects.
This trial tests a laser treatment that targets only the cancerous part of the prostate. It may be an option for men with intermediate-risk prostate cancer who do not want their entire prostate removed.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
This is a registry study that collects information from men with localized prostate cancer who receive transperineal laser ablation (a procedure done through the skin between the scrotum and anus). It may help doctors better understand outcomes and refine treatment choices over time.
This trial combines a biopsy (tissue sampling) with a heat-based ablation procedure in one visit to diagnose and treat early prostate cancer while also relieving severe urinary symptoms. It may help patients who need quick treatment and early discharge.
This study tests a new, less invasive treatment using targeted microwave ablation (TMA) to destroy prostate cancer tumors. It is designed for men with early-stage, low to intermediate-risk prostate cancer that hasn't spread, offering a possible alternative to surgery or radiation.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.